Berahyaluronidase Alfa and Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of pembrolizumab and berahyaluronidase alfa that can be used in the treatment of ampullary adenocarcinoma, small bowel adenocarcinoma, cutaneous and uveal melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell cancer (HNSCC), anal cancer, urothelial cancer, colorectal cancer, esophageal cancer, cervical cancer, ovarian cancer, fallopian tube cancer, primary peritoneal cancer, hepatocellular carcinoma, Merkel cell carcinoma, renal cell carcinoma, endometrial carcinoma, cutaneous squamous cell carcinoma, thymic carcinoma, occult primary cancer, penile cancer, prostate cancer, bone cancer, breast cancer, appendiceal cancer, vaginal cancer, vulvar cancer, biliary tract cancer, gastric cancer., and soft tissue sarcoma.

**Synonyms:** - Berahyaluronidase Alfa-pmph and Pembrolizumab Regimen - Keytruda Qlex Regimen - Pembrolizumab and Berahyaluronidase Alfa-pmph